Does MIANSERIN Cause Hepatic cytolysis? 74 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 74 reports of Hepatic cytolysis have been filed in association with MIANSERIN. This represents 2.9% of all adverse event reports for MIANSERIN.
74
Reports of Hepatic cytolysis with MIANSERIN
2.9%
of all MIANSERIN reports
36
Deaths
33
Hospitalizations
How Dangerous Is Hepatic cytolysis From MIANSERIN?
Of the 74 reports, 36 (48.6%) resulted in death, 33 (44.6%) required hospitalization, and 16 (21.6%) were considered life-threatening.
Is Hepatic cytolysis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MIANSERIN. However, 74 reports have been filed with the FAERS database.
What Other Side Effects Does MIANSERIN Cause?
Toxicity to various agents (246)
Fall (201)
Coma (177)
Somnolence (163)
Off label use (141)
Drug abuse (132)
Confusional state (126)
Hyponatraemia (122)
Hypotension (113)
Poisoning deliberate (107)
What Other Drugs Cause Hepatic cytolysis?
ACETAMINOPHEN (1,469)
ATORVASTATIN (681)
PEMBROLIZUMAB (601)
CARBOPLATIN (577)
METHOTREXATE (468)
SULFAMETHOXAZOLE\TRIMETHOPRIM (356)
PACLITAXEL (324)
ENOXAPARIN (307)
AMOXICILLIN (273)
VALACYCLOVIR (261)
Which MIANSERIN Alternatives Have Lower Hepatic cytolysis Risk?
MIANSERIN vs MICAFUNGIN
MIANSERIN vs MICARDIS
MIANSERIN vs MICONAZOLE
MIANSERIN vs MIDAZOLAM
MIANSERIN vs MIDAZOLAM\MIDAZOLAM